Cancer and Inflammation: Implications for Pharmacology and Therapeutics

被引：191

作者：

Balkwill, F. ^{[1
]}

Mantovani, A. ^{[2
]}

机构：

[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Canc, Ctr Canc & Inflammat, London, England

[2] Univ Milan, Ist Clin Humanitas, Milan, Italy

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷 / 04期

关键词：

NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; OVARIAN-CANCER; RHEUMATOID-ARTHRITIS; CXCR4; ANTAGONIST; PROGENITOR CELLS; PROSTATE-CANCER; TUMOR-GROWTH; INTERLEUKIN-6; CYTOKINE;

D O I：

10.1038/clpt.2009.312

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Smoldering, nonresolving inflammation is a component of the tumor microenvironment. The linkage between inflammation and cancer, first perceived in the nineteenth century, is now part of an accepted paradigm of carcinogenesis.

引用

页码：401 / 406

页数：6

共 52 条

[1] Cutaneous castleman's disease responds to anti-interleukin-6 treatment
Ahmed, Bilal
Tschen, Jaime A.
Cohen, Philip R.
Zaki, Mohamed H.
Rady, Peter L.
Tyring, Stephen K.
Corringham, Robert E.
Kurzrock, Razelle
[J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (09) : 2386 - 2390
[2] Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Ancrile, Brooke
Lim, Kian-Huat
Counter, Christopher M.
[J]. GENES & DEVELOPMENT, 2007, 21 (14) : 1714 - 1719
[3] Tumor necrosis factor-α in the pathogenesis and treatment of cancer
Anderson, GM
Nakada, MT
DeWitte, M
[J]. CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) : 314 - 320
[4] Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Apetoh, Lionel
Ghiringhelli, Francois
Tesniere, Antoine
Obeid, Michel
Ortiz, Carla
Criollo, Alfredo
Mignot, Gregoire
Maiuri, M. Chiara
Ullrich, Evelyn
Saulnier, Patrick
Yang, Huan
Amigorena, Sebastian
Ryffel, Bernard
Barrat, Franck J.
Saftig, Paul
Levi, Francis
Lidereau, Rosette
Nogues, Catherine
Mira, Jean-Paul
Chompret, Agnes
Joulin, Virginie
Clavel-Chapelon, Francoise
Bourhis, Jean
Andre, Fabrice
Delaloge, Suzette
Tursz, Thomas
Kroemer, Guido
Zitvogel, Laurence
[J]. NATURE MEDICINE, 2007, 13 (09) : 1050 - 1059
[5] Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells
Ara, Tasnim
Song, Liping
Shimada, Hiroyuki
Keshelava, Nino
Russell, Heidi V.
Metelitsa, Leonid S.
Groshen, Susan G.
Seeger, Robert C.
DeClerck, Yves A.
[J]. CANCER RESEARCH, 2009, 69 (01) : 329 - 337
[6] Malignancy and biologic therapy in rheumatoid arthritis
Askling, Johan
Bongartz, Tim
[J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (03) : 334 - 339
[7] BALKWILL F, NAT REV CAN IN PRESS
[8] gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
Bollrath, Julia
Phesse, Toby J.
von Burstin, Vivian A.
Putoczki, Tracy
Bennecke, Moritz
Bateman, Trudie
Nebelsiek, Tim
Lundgren-May, Therese
Canli, Oezge
Schwitalla, Sarah
Matthews, Vance
Schmid, Roland M.
Kirchner, Thomas
Arkan, Melek C.
Ernst, Matthias
Greten, Florian R.
[J]. CANCER CELL, 2009, 15 (02) : 91 - 102
[9] Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
Bongartz, T
Sutton, AJ
Sweeting, MJ
Buchan, I
Matteson, EL
Montori, V
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19): : 2275 - 2285
[10] BURGDORF SK, 2009, ACTA ONCOL, P1

← 1 2 3 4 5 6 →